MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
470.31%
Quick Ratio
470.31%
Cash Ratio
451.35%
Debt to Asset Ratio
100.74%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Restricted cash, net of current ...
    • Restricted cash, current portion
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Derivative tranche liability
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
86,398
99,209
109,517
75,255
Restricted cash, current portion
730
730
1,346
-
Prepaid expenses and other current assets
2,899
2,258
3,232
2,453
Total current assets
90,027
102,197
114,095
77,708
Restricted cash, net of current portion
894
894
894
1,624
Property and equipment, net
1,848
1,927
2,339
2,895
Operating lease right-of-use assets
591
363
397
4,078
Finance lease right-of-use assets
-
-
-
90
Other assets
68
76
83
-
Total assets
93,428
105,457
117,808
86,395
Accounts payable
1,093
863
182
585
Accrued expenses and other current liabilities
4,237
4,302
5,632
4,065
Current portion of deferred revenue
13,010
11,075
9,387
0
Operating lease liabilities, current portion
802
384
286
3,226
Finance lease liabilities, current portion
-
-
-
27
Financing liability, current portion
-
-
-
0
Other current liabilities
-
-
27
-
Total current liabilities
19,142
16,624
15,514
7,903
Deferred revenue, net of current portion
1,500
5,215
8,113
-
Operating lease liabilities, net of current portion
1,570
1,738
1,688
3,046
Finance lease liabilities, net of current portion
-
-
-
47
Derivative tranche liability
71,878
50,948
44,760
16,732
Other long-term liabilities
31
30
29
-
Total liabilities
94,121
74,555
70,104
27,728
Common stock, 0.0001 par value per share, 175,000,000 shares authorized as of june30, 2026 and december31, 2025, 51,926,988 and 51,902,614 shares issued and outstanding as of june30, 2026 and december31, 2025, respectively
6
6
6
5
Additional paid-in capital
343,318
341,383
339,854
310,534
Accumulated deficit
-344,017
-310,487
-292,156
-251,872
Total stockholders (deficit) equity
-693
30,902
47,704
58,667
Total liabilities and stockholders equity
93,428
105,457
117,808
86,395
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$86,398K (121.24%↑ Y/Y)Prepaid expenses andother current assets$2,899K (42.53%↑ Y/Y)Restricted cash, currentportion$730K Total current assets$90,027K (119.12%↑ Y/Y)Property and equipment,net$1,848K (-45.76%↓ Y/Y)Restricted cash, net ofcurrent portion$894K (-44.95%↓ Y/Y)Operating leaseright-of-use assets$591K (-88.32%↓ Y/Y)Other assets$68K Total assets$93,428K (82.21%↑ Y/Y)Accumulated deficit-$344,017K (-45.29%↓ Y/Y)Total liabilities andstockholders equity$93,428K (82.21%↑ Y/Y)Total stockholders(deficit) equity-$693K (-101.73%↓ Y/Y)Additional paid-in capital$343,318K (24.05%↑ Y/Y)Common stock, 0.0001par value per share,...$6K (200.00%↑ Y/Y)Total liabilities$94,121K (733.81%↑ Y/Y)Derivative trancheliability$71,878K Total currentliabilities$19,142K (160.97%↑ Y/Y)Operating leaseliabilities, net of current...$1,570K (-59.66%↓ Y/Y)Deferred revenue, net ofcurrent portion$1,500K Other long-termliabilities$31K (1450.00%↑ Y/Y)Current portion ofdeferred revenue$13,010K Accrued expenses andother current...$4,237K (47.63%↑ Y/Y)Accounts payable$1,093K (-8.54%↓ Y/Y)Operating leaseliabilities, current portion$802K (-74.52%↓ Y/Y)

Camp4 Therapeutics Corp (CAMP)

Camp4 Therapeutics Corp (CAMP)